BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients

  Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces the completion of a pediatric study of its marketed contraceptive ESTELLE® in adolescent women.

  December 20, 2023

   · 

  4 min read
• TheracosBio Announces Availability of BRENZAVVY® (bexagliflozin) Through DiRx’s National Online Pharmacy

  BRENZAVVY will be priced at $47.75 a month and eliminates hassles associated with insurance benefit design

  December 20, 2023

   · 

  10 min read
• Biotech Beach

  Inari Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference

  Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) announced today its management team will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 at 9:45AM Pacific Time.

  December 20, 2023

   · 

  1 min read
• Drug Development

  Inventiva announces the randomization of the first patient in China in the NATiV3 clinical trial and provides an update on its clinical development program

  Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”) today announced that the first patient has been randomized in China in the global NATiV3 Phase III clinical trial and provided an update on its clinical development program.

  December 20, 2023

   · 

  19 min read
• Policy

  ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices

  ResMed is conducting a voluntary global field action to update its guides for all masks with magnets to inform users about potential magnetic interference when magnets are near certain implants and medical devices in the body.

  December 20, 2023

   · 

  3 min read
• Business

  Atara Biotherapeutics Announces Closing of Expanded Global Tab-cel® Partnership with Pierre Fabre Laboratories

  Atara Biotherapeutics, Inc. (Nasdaq: ATRA) today announced the closing of the expanded global partnership with Pierre Fabre Laboratories for tabelecleucel (tab-cel® or EBVALLOTM).

  December 20, 2023

   · 

  5 min read
• AbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024

  AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 2:15 p.m. Pacific Time (5:15 p.m. Eastern Time).

  December 20, 2023

   · 

  1 min read
• Business

  Disc Medicine Announces Retirement of Brian MacDonald, MB, ChB, PhD as Chief Innovation Officer and Appointment as Chair of Scientific Advisory Board

  Disc Medicine, Inc. (NASDAQ:IRON) (“Disc”) announced today that, after a distinguished 28-year career, including over 6 years at Disc, Brian MacDonald, MB, ChB, PhD, will be retiring from his role as Chief Innovation Officer.

  December 20, 2023

   · 

  4 min read
• Business

  ACELYRIN, INC. Appoints Lynn Tetrault to Board of Directors

  ACELYRIN, INC., a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, announced the appointment of Lynn Tetrault to its board of directors.

  December 20, 2023

   · 

  3 min read
• BioCapital

  YS Biopharma Responds to Unauthorized Press Release Regarding Extraordinary General Meeting

  YS Biopharma Co., Ltd. issues an official response to the unauthorized press release disseminated under our name.

  December 20, 2023

   · 

  5 min read